pediaHorse chestnut extract is a botanical extract obtained from the seeds, bark or flowers of the Aesculus hippocastanum L. (family Sapindaceae) tree. This majestic tree, native to the Balkan Peninsula, has been known for a long time in European tradition. Its main component, aescin, a mixture of triterpene saponins, is studied in phytochemical literature; the medicinal uses of the substance belong to the context of human medicinal products and are outside the scope of this cosmetic monograph. In cosmetics, horse chestnut extract is preferred particularly in "leg" and "eye area" care products.
This article is not a product promotion. The information in the article contains no therapeutic claims.
Botanical source and history
Aesculus hippocastanum L. is a deciduous, majestic tree of the family Sapindaceae (soapberry family), reaching a height of 25-30 meters. It is native to the Balkan Peninsula (Greece, Albania, North Macedonia), but since the 16th century it has spread throughout Europe as a park and ornamental tree. It is also widespread in Türkiye as a park and avenue tree.
The shiny brown seeds inside the spiny capsule are known as "horse chestnuts". They should not be confused with the edible chestnut (Castanea sativa); horse chestnut seeds are toxic and should not be eaten. They have been traditionally used in Europe since the 16th century. The Latin name "hippocastanum" derives from the Latin words "hippo" (horse) and "castanum" (chestnut). According to one account, the Ottomans used the seeds of this tree against respiratory problems in horses.
Chemical profile
Aescin: the main component
Aescin is the most important bioactive component of the Aesculus hippocastanum seed. Aescin is a mixture of triterpene saponins and is divided into two main fractions, alpha-aescin and beta-aescin. Beta-aescin is considered the pharmacologically more active form. According to the EMA/HMPC assessment report, aescin (a mixture of acylated triterpene glycosides) is present in the seed at approximately 3-10%. Saponins are surface-active substances; when mixed with water they form foam. This property also contributes to the functionality of the extract in cosmetic products.
Other components
The seed also contains proanthocyanidins (oligomeric and polymeric, antioxidant), flavonoids (quercetin and kaempferol derivatives), coumarins (esculin, fraxin) and starch. Esculin is a coumarin derivative noted for its UV-B absorption capacity and has been investigated in some sun protection products.
| Component | Typical range | Note |
|---|---|---|
| Aescin | 3-10% (in seed; EMA/HMPC assessment report) | Triterpene saponin mixture; two main fractions, alpha-aescin and beta-aescin |
| Proanthocyanidins | — | Oligomeric and polymeric; antioxidant |
| Flavonoids | — | Quercetin and kaempferol derivatives |
| Coumarins | — | Esculin, fraxin; esculin is noted for its UV-B absorption capacity |
| Starch | — | — |
Place in the scientific literature
EMA monograph
The Committee on Herbal Medicinal Products (HMPC) of the European Medicines Agency (EMA) has published a European Union herbal monograph for Aesculus hippocastanum L. seed (Hippocastani semen) (EMA/HMPC/628242/2018, Final - Revision 1). The monograph evaluates seed preparations not only in the "traditional use" category, but also, for certain standardized preparations, in the "well-established use" category. This medicinal product context is outside the scope of this cosmetic ingredient monograph.
Scientific literature: scope note
This seed extract and its main component, aescin, have been widely studied in pharmacology literature. The medicinal/clinical uses in this literature belong to the context of human medicinal products and are outside the scope of this cosmetic ingredient monograph.
Anti-inflammatory mechanism
The anti-inflammatory effect of aescin is associated with mechanisms that reduce vascular permeability (preventing capillary leakage), inhibit phospholipase A2 and modulate leukocyte migration. These mechanisms are investigated in phytochemical literature.
Cosmetic use context
In the cosmetics industry, this botanical extract is used particularly in the following product categories: leg care creams (heaviness and fatigue sensation), eye area care products (puffiness and the appearance of dark circles), anti-cellulite products and "varicose vein care" products.
Safety profile
Extracts with standardized aescin preparations are generally considered safe for topical and oral use. The EMA monograph supports this safety profile. Rare allergic reactions are possible with topical use. Gastrointestinal irritation has been reported with oral use (food supplements). Raw horse chestnut seed is toxic (esculin content) and must never be consumed unprocessed. Pregnant women and individuals taking anticoagulants should consult a healthcare professional.
Horse chestnut in soap making
Method of use
This raw material, in liquid or glycerin-based extract form, is added at trace stage in small amounts (5-15 ml per 500 g of oil). A powdered extract form can also be used; it is recommended to disperse it beforehand with a small amount of water or oil.
Properties it adds to soap
This extract contributes a botanical active component (aescin) to the soap and has the potential to slightly support foam structure thanks to its natural saponins. It also gives a faint yellowish-brown tint. Its fragrance contribution is minimal. Horse chestnut soap forms a niche product category within the "natural care" segment.
Horse chestnut as a natural saponin
An interesting cultural note: these seeds have been used throughout history as "natural soap". Due to their saponin content, they form foam when mixed with water. This property shows the deep historical link between horse chestnut and soap making.
Horse chestnut and natural saponin soap making
Due to their saponin content, these seeds have been used throughout history as an alternative to "natural soap". The ability to form foam when mixed with water stems from the amphiphilic (both water-loving and fat-loving) structure of saponin molecules. This property has made the use of the same seeds for washing and cleaning popular within modern "zero waste" and "natural living" movements. In the context of soap making, this historical connection strengthens the conceptual basis for adding horse chestnut extract to soap recipes.
Frequently asked questions
What is horse chestnut extract?
Horse chestnut extract is a botanical extract obtained from the seeds of the Aesculus hippocastanum tree, rich in aescin. It is a component for which the EMA/HMPC has published a European Union herbal monograph (traditional use and well-established use categories).
What does horse chestnut do in soap?
It adds a botanical active component to the soap and slightly supports foam structure thanks to its natural saponins. It is added in small amounts (5-15 ml per 500 g of oil) at trace stage.
Is horse chestnut edible?
No. Horse chestnut (Aesculus hippocastanum) is different from the edible chestnut (Castanea sativa). Raw horse chestnut seeds are toxic. They should only be used in standardized extract form as a cosmetic or food supplement.
Why is my horse chestnut soap greenish?
Horse chestnut extract can give soap a faint yellowish-greenish tint. This color comes from the flavonoids and proanthocyanidins in the extract. The color intensity depends on the extract concentration and type (liquid vs. powder). Over time the soap's color may change slightly; this is normal for plant extracts.
Chailea products containing this ingredient
- Doğal Aktif Karbon Sabunu 100 g
References
1. EMA/HMPC (European Medicines Agency, Committee on Herbal Medicinal Products). European Union herbal monograph on Aesculus hippocastanum L., semen (Hippocastani semen), Final – Revision 1. EMA/HMPC/628242/2018. ema.europa.eu/en/medicines/herbal/hippocastani-semen
2. EMA/HMPC. Assessment report on Aesculus hippocastanum L., semen, Final – Revision 1. EMA/HMPC/638244/2018. PDF
3. Wilkinson, J. A., & Brown, A. M. (1999). Horse chestnut – Aesculus hippocastanum: potential applications in cosmetic skin-care products. International Journal of Cosmetic Science, 21(6), 437-447. doi:10.1046/j.1467-2494.1999.234192.x
4. Sirtori, C. R. (2001). Aescin: pharmacology, pharmacokinetics and therapeutic profile. Pharmacological Research, 44(3), 183-193. doi:10.1006/phrs.2001.0847